Publications by authors named "Philipp Haselmayer"

Claim this Profile
I
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies.
Matthew Studham, Cristina Vazquez-Mateo, Eileen Samy, Philipp Haselmayer, Aida Aydemir

ACR Open Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Jaromir Vlach, Andrew T Bender, Melinda Przetak, Albertina Pereira, Aditee Deshpande, Philipp Haselmayer

J Pharmacol Exp Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Bruton's tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.
Sebastian Torke, Roxanne Pretzsch, Darius Häusler, Philipp Haselmayer, Roland Grenningloh

Acta Neuropathol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson.
Sonja Hatz, Scott Spangler, Andrew Bender, Matthew Studham, Philipp Haselmayer

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
Philipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, Ngan Nguyen, Federica Morandi

J Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Philipp Haselmayer, Michele Vigolo, Josquin Nys, Pascal Schneider, Henry Hess

Eur J Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling.
Andrew T Bender, Anna Gardberg, Albertina Pereira, Theresa Johnson, Yin Wu, Philipp Haselmayer

Mol Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.
Philipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, Samer El Bawab, Caroline Waltzinger

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.
Gerd Gladigau, Philipp Haselmayer, Inge Scharrer, Markus Munder, Nadine Prinz

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling pathways of the TREM-1- and TLR4-mediated neutrophil oxidative burst.
Philipp Haselmayer, Martin Daniel, Christine Tertilt, Helmut R Salih, Michael Stassen

J Innate Immun· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease.
Markus P Radsak, Christian Taube, Philipp Haselmayer, Stefan Tenzer, Helmut R Salih

Clin Dev Immunol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TREM-1 ligand expression on platelets enhances neutrophil activation.
Philipp Haselmayer, Ludger Grosse-Hovest, Philipp von Landenberg, Hansjörg Schild, Markus P Radsak

Blood· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses.
Philipp Haselmayer, Stefan Tenzer, Byoung S Kwon, Gundram Jung, Hansjörg Schild

Immunology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.
Tobias Warger, Nobert Hilf, Gerd Rechtsteiner, Philipp Haselmayer, Deanna M Carrick

J Biol Chem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis